Efficacy_of_eyedrops_containing_crosslinked_hyaluronic_acid-1.jpg

Efficacy and safety of a collyrium based on crosslinked hyaluronic acid (XLHA) with coenzyme Q10

Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye

Article specifications

This original article was published in 2017 in Journal of European journal of ophthalmology (IF 2017: 0.16) by Italian specialists. The aim of this study was to evaluate the efficacy and safety of a collyrium based on crosslinked hyaluronic acid (XLHA) with coenzyme Q10 (CoQ10). Enrolled subjects were divided into 2 groups: group A, treated with XLHA + CoQ10; and group B, treated with hyaluronic acid (HA). Eyedrops were administered 4 times daily for 3 months.

 

Results

The XLHA + CoQ10 treatment showed greater electiveness in DED compared to HA alone, probably due to the longer permanency on ocular surface and the antioxidant activity of CoQ10. Therefore, XLHA + CoQ10 eyedrops could represent a new possibility in dry eye treatment.

Tags: Italy European journal of ophthalmology Original research 2017

Hayland Center

© 2018 HYLAND.CENTER ALL RIGHTS RESERVED